Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Debt / NOTE 2.500%11/0
-
Market price (% of par)
-
245.13%
-
Total 13F principal
-
$212,089,475
-
Principal change
-
+$1,525,939
-
Total reported market value
-
$520,180,067
-
Number of holders
-
34
-
Value change
-
+$2,931,738
-
Number of buys
-
9
-
Number of sells
-
14
Institutional Holders of CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 as of Q2 2014
As of 30 Jun 2014,
CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 was held by
34 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$212,089,475
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, Polar Securities Inc., BlackRock Advisors LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WHITEBOX ADVISORS LLC, ROYAL BANK OF CANADA, BlackRock Institutional Trust Company, N.A., BANK OF AMERICA CORP /DE/, BlackRock Group LTD, and DEUTSCHE BANK AG\.
This page lists
34
institutional bondholders reporting positions
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.